Advertisement
Screener

Connect Biopharma Holdings Limited (CNTB) Revenue From Contracts With Customers

2.8 / 5 stars · 68/120 Roast Me

Connect Biopharma Holdings Limited Revenue From Contracts With Customers

Connect Biopharma Holdings Limited (CNTB) reported Revenue From Contracts With Customers of CNY 171.60 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.

Discontinued › Income Statement › Other Income

ifrs-full:RevenueFromContractsWithCustomers · last filed 2024-09-05

  • 2024-06-30: Revenue From Contracts With Customers 6 month 171.60M CNY.

CNY

Period endRevenue From Contracts With Customers 6 month
2024-06-30171.60M CNY
6-K · filed 2024-09-05

USD

Period endRevenue From Contracts With Customers 6 month
2024-06-30$24.12M
6-K · filed 2024-09-05
2023-06-30$0.00
6-K · filed 2024-09-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Yarrow Bioscience, Inc. (YARW)United States$0.070B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
XBiotech Inc. (XBIT)United States$0.066B-1.56
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
HYPERION DEFI, INC. (HYPD)United States$0.065B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57